SCHEMBL21921090

SCHEMBL21921090

O=C(NCc1ccc(OCC(F)(F)F)cn1)c1ccc(OCCF)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 1/20 0.50
HPGD P15428 2/20 0.48
HSD17B10 Q99714 1/20 0.48
MAPK14 Q16539 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
LMNA P02545 2/20 0.42
TSHR P16473 1/20 0.42
EPHX2 P34913 3/20 0.41
CTDSP1 Q9GZU7 1/20 0.40
NAMPT P43490 1/20 0.40
POLB P06746 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MMP13 P45452 1/20 0.39
CYP1A2 P05177 1/20 0.38
MAPT P10636 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2133636 0.93 RAB9A (0.56) SMN1; SMN2NPC1RAB9AHPGDHSD17B10
SCHEMBL2136526 0.86 EPHX2 (0.52) SMN1; SMN2NPC1RAB9AMAPK14MEN1
SCHEMBL2137668 0.86 NPC1 (0.54) SMN1; SMN2NPC1RAB9AHPGDHSD17B10
SCHEMBL2137173 0.85 EPHX2 (0.54) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL17240523 0.82 RAB9A (0.46) SMN1; SMN2NPC1RAB9AHPGDHSD17B10
SCHEMBL21921103 0.81 NPC1 (0.45) SMN1; SMN2NPC1RAB9AHPGDHSD17B10
SCHEMBL21921172 0.81 NPC1 (0.47) SMN1; SMN2NPC1RAB9AHPGDHSD17B10
SCHEMBL2137785 0.81 HTT (0.47) SMN1; SMN2NPC1RAB9AMAPK14KMT2A
SCHEMBL2136407 0.77 NAMPT (0.51) MAPK14NAMPT
SCHEMBL2143239 0.77 ALDH1A1 (0.53) SMN1; SMN2NPC1RAB9AHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3632899-A1 ARYL SUBSTITUTED CARBOXAMIDE DERIVATIVES AS CALCIUM OR SODIUM CHANNEL BLOCKERS RaQualia Pharma Inc. (JP) 2020-04-08 EP disclosed